Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BSX

Boston Scientific Corp

Feb 06 • 04:00PM ET

76.27

-1.37 -1.76 %

Healthcare • Medical Devices • USA • NYSE

Feb 06, 8:15 AMStifel cuts its price target on Boston Scientific to $110 from $125 while reiterating a Buy rating following the company’s recent quarterly report.

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO VUG IVV SPY XLV VHT IHI MGK SPYM

Index	S&P 500	P/E	39.33	EPS (ttm)	1.94	Insider Own	0.38%	Shs Outstand	1.48B	Perf Week	-18.45%
Market Cap	113.11B	Forward P/E	19.42	EPS next Y	3.93	Insider Trans	-5.91%	Shs Float	1.48B	Perf Month	-22.69%
Enterprise Value	124.02B	PEG	1.46	EPS next Q	0.79	Inst Own	94.06%	Short Float	1.58%	Perf Quarter	-22.88%
Income	2.90B	P/S	5.63	EPS this Y	13.24%	Inst Trans	0.36%	Short Ratio	1.94	Perf Half Y	-25.92%
Sales	20.07B	P/B	4.83	EPS next Y	13.36%	ROA	6.91%	Short Interest	23.42M	Perf YTD	-20.01%
Book/sh	15.78	P/C	82.38	EPS next 5Y	13.34%	ROE	12.66%	52W High	109.50 -30.35%	Perf Year	-27.34%
Cash/sh	0.93	P/FCF	29.58	EPS past 3/5Y	63.25% -	ROIC	8.29%	52W Low	74.86 1.88%	Perf 3Y	60.43%
Dividend Est.	-	EV/EBITDA	25.84	Sales past 3/5Y	16.54% 15.16%	Gross Margin	70.32%	Volatility	4.95% 3.08%	Perf 5Y	112.16%
Dividend TTM	-	EV/Sales	6.18	EPS Y/Y TTM	55.39%	Oper. Margin	19.43%	ATR (14)	3.35	Perf 10Y	335.08%
Dividend Ex-Date	-	Quick Ratio	0.96	Sales Y/Y TTM	19.88%	Profit Margin	14.44%	RSI (14)	24.14	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	1.51	EPS Q/Q	18.30%	SMA20	-15.53%	Beta	0.70	Target Price	105.37
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	15.90%	SMA50	-18.78%	Rel Volume	2.68	Prev Close	77.64
Employees	53000	LT Debt/Eq	0.49	Earnings	Feb 04 BMO	SMA200	-23.90%	Avg Volume	12.06M	Price	76.27
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.49% 0.12%	Trades		Volume	32,296,591	Change	-1.76%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Feb-06-26 09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
08:08AM	Boston Scientific price target lowered to $110 from $125 at Stifel (TipRanks)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
09:45AM	Loading…
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
09:25AM	STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading (Zacks)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:23AM	Boston Scientifics shares tumble 18% despite strong FY25 growth (Medical Device Network)
05:44AM	J.P. Morgan Healthcare Conference 2026 Report (Pharmaceutical Technology)
12:34AM	BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics (StockStory)
12:07AM	Boston Scientific Q4 Earnings Call Highlights (MarketBeat)
Feb-04-26 05:41PM	Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors (Motley Fool) -17.59%
04:41PM	These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More (Barrons.com)
04:09PM	Boston Scientific Hits An 18-Month Low On A 'Sore Spot' For Its Most Hyped Device (Investor's Business Daily)
02:03PM	Loading…
02:03PM	Boston Scientific Corp (BSX) Q4 2025 Earnings Call Highlights: Surpassing Financial Goals with ... (GuruFocus.com)
01:56PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
01:21PM	Why Boston Scientific Stock Plummeted Today (Motley Fool)
01:20PM	Software Stocks Plummet, Bitcoin Erases Post-Trump Election Rally: What's Moving Markets Wednesday? (Benzinga)
01:16PM	Boston Scientific (BSX) Earnings Transcript (Motley Fool)
12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
12:47PM	Stock Market Today: Dow Rises, Nasdaq Sinks Amid Tech Sell-Off; This Medical Stock Tumbles (Live Coverage) (Investor's Business Daily)
12:25PM	Why Boston Scientific (BSX) Shares Are Getting Obliterated Today (StockStory)
12:15PM	BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat (Zacks)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:55AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
10:42AM	Texas Instruments to buy Silicon Labs, Enphase stock surges 40% (Yahoo Finance Video)
10:32AM	AMD Earnings Beat Expectations. Why Its One of the S&P 500s Worst Stocks Today. (Barrons.com)
10:30AM	Boston Scientific Earnings Beat Estimates. Its the Worst Stock in the S&P 500 Today. (Barrons.com)
10:03AM	Loading…
10:03AM	Boston Scientific Stock Hits 52-Week Low On Soft 2026 Outlook (Benzinga)
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
09:30AM	Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
09:19AM	Boston Scientific Profit, Sales Rise but Issues Soft Guidance (The Wall Street Journal)
08:12AM	Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. (Barrons.com)
08:02AM	Boston Scientific shares slide on cautious 2026 revenue forecast (Reuters)
07:40AM	Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:41AM	Boston Scientific: Q4 Earnings Snapshot (Associated Press Finance)
06:40AM	Boston Scientific (NYSE:BSX) Reports Q4 CY2025 In Line With Expectations (StockStory)
06:30AM	Boston Scientific announces results for fourth quarter and full year 2025 (PR Newswire)
05:24AM	Uber and Alphabet headline earnings slate (MarketWatch)
04:36AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
04:24AM	Stock Market Today: Dow, S&P 500 and Nasdaq consolidate after software rout; AMD results weigh; Alphabet earnings on tap; gold recovers $5,000 level. (MarketWatch)
Feb-03-26 01:13PM	GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut (Zacks)
12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 10:03PM	Earnings To Watch: Boston Scientific (BSX) Reports Q4 Results Tomorrow (StockStory)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
09:51AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 11:13PM	Deal fever returns: 2026 looks hot for M&A (TheStreet)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
02:31PM	Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition (Insider Monkey)
01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
12:07PM	SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval (Zacks)
10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
09:15AM	Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Jan-29-26 01:32PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
08:48AM	Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
01:38AM	Boston Scientific Stock: Analyst Estimates & Ratings (Barchart)
Jan-28-26 12:35PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks)
11:26AM	QT Imaging & Olea Medical Partner to Enhance Cloud Imaging Platform (Zacks)
09:04AM	Boston Scientific Corporation (BSX): A Bull Case Theory (Insider Monkey)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:27AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings? (Zacks)
Jan-27-26 12:07PM	ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures (Zacks)
11:47AM	BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry (Zacks)
07:53AM	CLPT Gets EU MDR Certification for ClearPoint Navigation Software (Zacks)
Jan-26-26 03:09PM	Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage (CNBC TV)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
07:24AM	Boston Scientific touts long-term data of SCS therapy (Medical Device Network)
05:39AM	Medtronic wins CE mark for single-shot pulsed field ablation catheter (MedTech Dive)
05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-24-26 01:18AM	Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. (Barrons.com)
Jan-23-26 10:58PM	Oppenheimer Questions Valuation of Boston Scientific's $14.5 Billion Penumbra Deal (Insider Monkey)
06:00PM	Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider (Zacks)
11:43AM	ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Jan-22-26 09:52PM	Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance (Insider Monkey)
12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
Jan-21-26 07:07PM	J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll (Investor's Business Daily)
12:30PM	Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface (Benzinga)
10:49AM	CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February (Zacks)
08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:58AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 01:39PM	Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now? (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Option Exercise	25.78	95,754	2,468,482	1,572,636	Feb 03 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Sale	93.49	160,901	15,043,394	1,411,735	Feb 03 04:12 PM
MICHAEL F MAHONEY	Officer	Feb 02 '26	Proposed Sale	93.49	160,901	15,043,390		Feb 02 04:12 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Option Exercise	24.81	17,313	429,491	40,913	Dec 02 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Sale	101.55	17,313	1,758,189	23,600	Dec 02 05:04 PM
ARTHUR C BUTCHER	Officer	Dec 01 '25	Proposed Sale	101.55	17,313	1,758,188		Dec 01 04:02 PM
Zane Ellen M	Director	Nov 06 '25	Sale	98.28	12,891	1,266,978	24,134	Nov 06 04:34 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Nov 04 04:15 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Sale	99.47	50,000	4,973,338	178,342	Nov 04 04:15 PM
JOSEPH M FITZGERALD	Officer	Nov 03 '25	Proposed Sale	99.47	50,000	4,973,335		Nov 03 04:05 PM
Zane Ellen M	Director	Oct 27 '25	Sale	101.13	9,990	1,010,301	27,035	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Sale	102.24	2,901	296,599	24,134	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Proposed Sale	102.24	2,901	296,592		Oct 28 10:55 AM
Zane Ellen M	Director	Oct 27 '25	Proposed Sale	100.91	9,990	1,008,081		Oct 27 10:50 AM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM

Open in Screener

HOLX

Hologic, Inc

Feb 06 • 04:00PM ET

74.81

+0.11 0.15 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IHI IWR

Index	S&P 500	P/E	31.04	EPS (ttm)	2.41	Insider Own	1.52%	Shs Outstand	223.07M	Perf Week	-0.16%
Market Cap	16.70B	Forward P/E	15.26	EPS next Y	4.90	Insider Trans	-4.12%	Shs Float	219.86M	Perf Month	-0.20%
Enterprise Value	16.86B	PEG	1.87	EPS next Q	1.08	Inst Own	96.31%	Short Float	1.73%	Perf Quarter	0.78%
Income	543.90M	P/S	4.05	EPS this Y	5.04%	Inst Trans	-4.55%	Short Ratio	1.33	Perf Half Y	10.13%
Sales	4.13B	P/B	3.18	EPS next Y	9.59%	ROA	6.07%	Short Interest	3.79M	Perf YTD	0.43%
Book/sh	23.51	P/C	7.06	EPS next 5Y	8.16%	ROE	10.86%	52W High	75.36 -0.73%	Perf Year	2.76%
Cash/sh	10.59	P/FCF	17.45	EPS past 3/5Y	-21.45% -10.02%	ROIC	7.01%	52W Low	51.90 44.14%	Perf 3Y	-9.63%
Dividend Est.	-	EV/EBITDA	13.36	Sales past 3/5Y	-5.53% 1.66%	Gross Margin	55.62%	Volatility	0.37% 0.32%	Perf 5Y	-9.75%
Dividend TTM	-	EV/Sales	4.09	EPS Y/Y TTM	-23.89%	Oper. Margin	23.66%	ATR (14)	0.27	Perf 10Y	120.42%
Dividend Ex-Date	-	Quick Ratio	3.32	Sales Y/Y TTM	2.17%	Profit Margin	13.18%	RSI (14)	48.70	Recom	3.06
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	-8.44%	SMA20	-0.19%	Beta	0.73	Target Price	76.50
Payout	0.00%	Debt/Eq	0.48	Sales Q/Q	2.54%	SMA50	-0.09%	Rel Volume	1.09	Prev Close	74.70
Employees	7070	LT Debt/Eq	0.48	Earnings	Jan 29 AMC	SMA200	9.77%	Avg Volume	2.86M	Price	74.81
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.08% -2.20%	Trades		Volume	3,099,890	Change	0.15%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-26	Downgrade	Argus	Buy → Hold
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$78
Nov-21-25	Downgrade	BNP Paribas Exane	Outperform → Neutral	$79
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$78
Aug-18-25	Upgrade	Argus	Hold → Buy	$80
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75

Show Previous Ratings

Feb-06-26 11:45AM	Analyst Report: Hologic, Inc. (Morningstar Research)
Feb-04-26 08:15AM	Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio (Business Wire)
Feb-03-26 01:02PM	Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact (GuruFocus.com)
Feb-02-26 09:15AM	Hologic (HOLX) International Revenue Performance Explored (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:28AM	Loading…
Jan-30-26 08:28AM	HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash (Zacks)
Jan-29-26 08:42PM	Blackstone Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates (Zacks)
04:19PM	Hologic: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:11PM	Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates (StockStory)
04:02PM	Hologic Announces Financial Results for First Quarter of Fiscal 2026 (Business Wire)
12:51PM	Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? (Zacks)
Jan-28-26 08:24AM	SYK's Q4 Results Likely to Reflect Procedure Growth and Capital Demand (Zacks)
06:46AM	Medtech M&A took off in the second half of 2025: report (MedTech Dive)
10:10PM	Loading…
Jan-27-26 10:10PM	Hologic (HOLX) Q4 Earnings: What To Expect (StockStory)
Jan-26-26 09:15AM	Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Jan-23-26 04:20PM	Analysts consider potential Qiagen deal amid reported strategic review (Investing.com)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
Jan-22-26 10:00AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:50AM	Hologic Q1 Earnings Preview: How Should You Play the Stock Now? (Zacks)
Jan-21-26 12:10PM	Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:51AM	Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? (Zacks)
Jan-20-26 11:34PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Jan-19-26 06:02PM	Hologic, Inc. (HOLX): A Bear Case Theory (Insider Monkey)
07:52AM	HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? (Zacks)
Jan-16-26 11:56AM	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic (PR Newswire)
09:00AM	Loading…
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:18AM	Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening (Zacks)
Jan-15-26 11:37PM	1 Healthcare Stock Worth Investigating and 2 That Underwhelm (StockStory)
Jan-13-26 09:00AM	Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening (Business Wire)
Jan-10-26 03:00PM	More Bonds Are Teetering on the Brink of Junk: Credit Weekly (Bloomberg)
Jan-09-26 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jan-08-26 11:51AM	Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:40AM	HOLX vs. SONVY: Which Stock Should Value Investors Buy Now? (Zacks)
06:44AM	What You Need To Know Ahead of Hologic's Earnings Release (Barchart)
Jan-07-26 11:40AM	HOLX or SONVY: Which Is the Better Value Stock Right Now? (Zacks)
Jan-06-26 11:40AM	HOLX vs. SONVY: Which Stock Is the Better Value Option? (Zacks)
08:17AM	Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? (Zacks)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Dec-31-25 08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
07:25AM	Smart Oncology: 5 Stocks Chasing the $317B Prize (PR Newswire)
Dec-26-25 07:53AM	Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth (Zacks)
Dec-24-25 10:31PM	Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 (StockStory)
Dec-23-25 06:56PM	Halper Sadeh LLC Encourages SNCR, HOLX, FRGE Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Dec-22-25 07:58AM	HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? (Zacks)
Dec-18-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Dec-17-25 12:01PM	HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases (Zacks)
09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
08:26AM	Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers (Zacks)
Dec-12-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:34AM	What Is Driving Hologic's Strength in the US Diagnostics Market? (Zacks)
04:04AM	Is Hologic Stock Outperforming the Nasdaq? (Barchart)
Dec-11-25 08:54PM	Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-07-25 11:37PM	1 Mooning Stock on Our Watchlist and 2 Facing Headwinds (StockStory)
Dec-06-25 01:25PM	US Loses Financing Edge as Asia Borrows in Euros: Credit Weekly (Bloomberg)
Dec-04-25 10:23AM	Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions (Zacks)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:30AM	Why Is Hologic (HOLX) Up 1% Since Last Earnings Report? (Zacks)
Dec-02-25 08:10AM	New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration (Business Wire)
Dec-01-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-27-25 08:23AM	HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? (Zacks)
Nov-26-25 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-25-25 08:08AM	New Clinical Evidence on Hologics AI-Powered Mammography Solutions Will Be Unveiled at RSNA (Business Wire)
Nov-21-25 09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
07:13AM	Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It? (Zacks)
Nov-20-25 09:31AM	US healthcare group Abbott bets on cancer screening technology in $23bn deal (Financial Times)
Nov-19-25 11:02PM	3 Reasons HOLX is Risky and 1 Stock to Buy Instead (StockStory)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Nov-14-25 04:01PM	VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... (GuruFocus.com)
03:19PM	Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-12-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:11AM	Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking (Business Wire)
Nov-11-25 11:41AM	The transatlantic medtech investment gap: why does it exist and can it be plugged? (Medical Device Network)
Nov-10-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Nov-07-25 04:36PM	Halper Sadeh LLC Encourages IMXI, CMA, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
07:37AM	Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal (Zacks)
Nov-04-25 08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
Nov-03-25 06:45PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:30PM	Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:15PM	Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:28PM	Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations (StockStory)
04:22PM	Hologic: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 (Business Wire)
Nov-01-25 11:06PM	Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-30-25 12:25PM	Halper Sadeh LLC Encourages HOLX, FITB, HSII Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:06AM	HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? (Zacks)
Oct-29-25 09:15AM	Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-28-25 10:00AM	Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-27-25 10:00AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stamoulis Christiana	Director	Oct 20 '25	Option Exercise	36.04	7,402	266,768	54,738	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Sale	73.07	7,402	540,864	47,336	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Proposed Sale	73.07	7,402	540,864		Oct 20 10:12 AM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Option Exercise	39.96	138,358	5,528,786	1,372,982	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Sale	66.97	138,358	9,266,118	1,234,624	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Officer	Sep 22 '25	Proposed Sale	66.98	138,358	9,266,548		Sep 22 04:25 PM
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM

BSX

Boston Scientific Corp

HOLX

Hologic, Inc

Upgrade your FINVIZ experience